Global Oncolytic Virus Drug Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Oncolytic Virus Drug Treatment Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Drug Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Drug Treatment sales for 2023 through 2029. With Oncolytic Virus Drug Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Drug Treatment industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Drug Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Virus Drug Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Drug Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Drug Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Drug Treatment.
The global Oncolytic Virus Drug Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncolytic Virus Drug Treatment players cover Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Drug Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Oncolytic Virus Drug Treatment Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Drug Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Drug Treatment sales for 2023 through 2029. With Oncolytic Virus Drug Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Drug Treatment industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Drug Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Virus Drug Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Drug Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Drug Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Drug Treatment.
The global Oncolytic Virus Drug Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncolytic Virus Drug Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncolytic Virus Drug Treatment players cover Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Drug Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Phase 1
- Phase 2
- Others
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Drug Treatment Market Size 2018-2029
2.1.2 Oncolytic Virus Drug Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncolytic Virus Drug Treatment Segment by Type
2.2.1 Phase
2.2.2 Phase
2.2.3 Others
2.3 Oncolytic Virus Drug Treatment Market Size by Type
2.3.1 Oncolytic Virus Drug Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
2.4 Oncolytic Virus Drug Treatment Segment by Application
2.4.1 Melanoma
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Ovarian Cancer
2.4.5 Others
2.5 Oncolytic Virus Drug Treatment Market Size by Application
2.5.1 Oncolytic Virus Drug Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
3 ONCOLYTIC VIRUS DRUG TREATMENT MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Drug Treatment Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023)
3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Drug Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS DRUG TREATMENT BY REGIONS
4.1 Oncolytic Virus Drug Treatment Market Size by Regions (2018-2023)
4.2 Americas Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.3 APAC Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.4 Europe Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
5.2 Americas Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
5.3 Americas Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Drug Treatment Market Size by Region (2018-2023)
6.2 APAC Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
6.3 APAC Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Drug Treatment by Country (2018-2023)
7.2 Europe Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
7.3 Europe Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Drug Treatment by Region (2018-2023)
8.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS DRUG TREATMENT MARKET FORECAST
10.1 Global Oncolytic Virus Drug Treatment Forecast by Regions (2024-2029)
10.1.1 Global Oncolytic Virus Drug Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Oncolytic Virus Drug Treatment Forecast
10.1.3 APAC Oncolytic Virus Drug Treatment Forecast
10.1.4 Europe Oncolytic Virus Drug Treatment Forecast
10.1.5 Middle East & Africa Oncolytic Virus Drug Treatment Forecast
10.2 Americas Oncolytic Virus Drug Treatment Forecast by Country (2024-2029)
10.2.1 United States Oncolytic Virus Drug Treatment Market Forecast
10.2.2 Canada Oncolytic Virus Drug Treatment Market Forecast
10.2.3 Mexico Oncolytic Virus Drug Treatment Market Forecast
10.2.4 Brazil Oncolytic Virus Drug Treatment Market Forecast
10.3 APAC Oncolytic Virus Drug Treatment Forecast by Region (2024-2029)
10.3.1 China Oncolytic Virus Drug Treatment Market Forecast
10.3.2 Japan Oncolytic Virus Drug Treatment Market Forecast
10.3.3 Korea Oncolytic Virus Drug Treatment Market Forecast
10.3.4 Southeast Asia Oncolytic Virus Drug Treatment Market Forecast
10.3.5 India Oncolytic Virus Drug Treatment Market Forecast
10.3.6 Australia Oncolytic Virus Drug Treatment Market Forecast
10.4 Europe Oncolytic Virus Drug Treatment Forecast by Country (2024-2029)
10.4.1 Germany Oncolytic Virus Drug Treatment Market Forecast
10.4.2 France Oncolytic Virus Drug Treatment Market Forecast
10.4.3 UK Oncolytic Virus Drug Treatment Market Forecast
10.4.4 Italy Oncolytic Virus Drug Treatment Market Forecast
10.4.5 Russia Oncolytic Virus Drug Treatment Market Forecast
10.5 Middle East & Africa Oncolytic Virus Drug Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Oncolytic Virus Drug Treatment Market Forecast
10.5.2 South Africa Oncolytic Virus Drug Treatment Market Forecast
10.5.3 Israel Oncolytic Virus Drug Treatment Market Forecast
10.5.4 Turkey Oncolytic Virus Drug Treatment Market Forecast
10.5.5 GCC Countries Oncolytic Virus Drug Treatment Market Forecast
10.6 Global Oncolytic Virus Drug Treatment Forecast by Type (2024-2029)
10.7 Global Oncolytic Virus Drug Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Oncolytic Virus Drug Treatment Product Offered
11.1.3 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Information
11.2.2 Oncolytics Biotech Oncolytic Virus Drug Treatment Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Oncolytics Biotech Main Business Overview
11.2.5 Oncolytics Biotech Latest Developments
11.3 Viralytics
11.3.1 Viralytics Company Information
11.3.2 Viralytics Oncolytic Virus Drug Treatment Product Offered
11.3.3 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Viralytics Main Business Overview
11.3.5 Viralytics Latest Developments
11.4 Transgene SA
11.4.1 Transgene SA Company Information
11.4.2 Transgene SA Oncolytic Virus Drug Treatment Product Offered
11.4.3 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Transgene SA Main Business Overview
11.4.5 Transgene SA Latest Developments
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Information
11.5.2 Oncolys BioPharma Oncolytic Virus Drug Treatment Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Oncolys BioPharma Main Business Overview
11.5.5 Oncolys BioPharma Latest Developments
11.6 Targovax
11.6.1 Targovax Company Information
11.6.2 Targovax Oncolytic Virus Drug Treatment Product Offered
11.6.3 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Targovax Main Business Overview
11.6.5 Targovax Latest Developments
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Information
11.7.2 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PsiOxus Therapeutics Main Business Overview
11.7.5 PsiOxus Therapeutics Latest Developments
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Information
11.8.2 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 SillaJen Biotherapeutics Main Business Overview
11.8.5 SillaJen Biotherapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Information
11.10.2 Lokon Pharma Oncolytic Virus Drug Treatment Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lokon Pharma Main Business Overview
11.10.5 Lokon Pharma Latest Developments
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Information
11.11.2 Genelux Corporation Oncolytic Virus Drug Treatment Product Offered
11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genelux Corporation Main Business Overview
11.11.5 Genelux Corporation Latest Developments
11.12 Vyriad
11.12.1 Vyriad Company Information
11.12.2 Vyriad Oncolytic Virus Drug Treatment Product Offered
11.12.3 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Vyriad Main Business Overview
11.12.5 Vyriad Latest Developments
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Information
11.13.2 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 TILT Biotherapeutics Main Business Overview
11.13.5 TILT Biotherapeutics Latest Developments
11.14 Cold Genesys
11.14.1 Cold Genesys Company Information
11.14.2 Cold Genesys Oncolytic Virus Drug Treatment Product Offered
11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Cold Genesys Main Business Overview
11.14.5 Cold Genesys Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Drug Treatment Market Size 2018-2029
2.1.2 Oncolytic Virus Drug Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncolytic Virus Drug Treatment Segment by Type
2.2.1 Phase
2.2.2 Phase
2.2.3 Others
2.3 Oncolytic Virus Drug Treatment Market Size by Type
2.3.1 Oncolytic Virus Drug Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
2.4 Oncolytic Virus Drug Treatment Segment by Application
2.4.1 Melanoma
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Ovarian Cancer
2.4.5 Others
2.5 Oncolytic Virus Drug Treatment Market Size by Application
2.5.1 Oncolytic Virus Drug Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
3 ONCOLYTIC VIRUS DRUG TREATMENT MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Drug Treatment Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023)
3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Drug Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS DRUG TREATMENT BY REGIONS
4.1 Oncolytic Virus Drug Treatment Market Size by Regions (2018-2023)
4.2 Americas Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.3 APAC Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.4 Europe Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncolytic Virus Drug Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
5.2 Americas Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
5.3 Americas Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Drug Treatment Market Size by Region (2018-2023)
6.2 APAC Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
6.3 APAC Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Drug Treatment by Country (2018-2023)
7.2 Europe Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
7.3 Europe Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Drug Treatment by Region (2018-2023)
8.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS DRUG TREATMENT MARKET FORECAST
10.1 Global Oncolytic Virus Drug Treatment Forecast by Regions (2024-2029)
10.1.1 Global Oncolytic Virus Drug Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Oncolytic Virus Drug Treatment Forecast
10.1.3 APAC Oncolytic Virus Drug Treatment Forecast
10.1.4 Europe Oncolytic Virus Drug Treatment Forecast
10.1.5 Middle East & Africa Oncolytic Virus Drug Treatment Forecast
10.2 Americas Oncolytic Virus Drug Treatment Forecast by Country (2024-2029)
10.2.1 United States Oncolytic Virus Drug Treatment Market Forecast
10.2.2 Canada Oncolytic Virus Drug Treatment Market Forecast
10.2.3 Mexico Oncolytic Virus Drug Treatment Market Forecast
10.2.4 Brazil Oncolytic Virus Drug Treatment Market Forecast
10.3 APAC Oncolytic Virus Drug Treatment Forecast by Region (2024-2029)
10.3.1 China Oncolytic Virus Drug Treatment Market Forecast
10.3.2 Japan Oncolytic Virus Drug Treatment Market Forecast
10.3.3 Korea Oncolytic Virus Drug Treatment Market Forecast
10.3.4 Southeast Asia Oncolytic Virus Drug Treatment Market Forecast
10.3.5 India Oncolytic Virus Drug Treatment Market Forecast
10.3.6 Australia Oncolytic Virus Drug Treatment Market Forecast
10.4 Europe Oncolytic Virus Drug Treatment Forecast by Country (2024-2029)
10.4.1 Germany Oncolytic Virus Drug Treatment Market Forecast
10.4.2 France Oncolytic Virus Drug Treatment Market Forecast
10.4.3 UK Oncolytic Virus Drug Treatment Market Forecast
10.4.4 Italy Oncolytic Virus Drug Treatment Market Forecast
10.4.5 Russia Oncolytic Virus Drug Treatment Market Forecast
10.5 Middle East & Africa Oncolytic Virus Drug Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Oncolytic Virus Drug Treatment Market Forecast
10.5.2 South Africa Oncolytic Virus Drug Treatment Market Forecast
10.5.3 Israel Oncolytic Virus Drug Treatment Market Forecast
10.5.4 Turkey Oncolytic Virus Drug Treatment Market Forecast
10.5.5 GCC Countries Oncolytic Virus Drug Treatment Market Forecast
10.6 Global Oncolytic Virus Drug Treatment Forecast by Type (2024-2029)
10.7 Global Oncolytic Virus Drug Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Oncolytic Virus Drug Treatment Product Offered
11.1.3 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Information
11.2.2 Oncolytics Biotech Oncolytic Virus Drug Treatment Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Oncolytics Biotech Main Business Overview
11.2.5 Oncolytics Biotech Latest Developments
11.3 Viralytics
11.3.1 Viralytics Company Information
11.3.2 Viralytics Oncolytic Virus Drug Treatment Product Offered
11.3.3 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Viralytics Main Business Overview
11.3.5 Viralytics Latest Developments
11.4 Transgene SA
11.4.1 Transgene SA Company Information
11.4.2 Transgene SA Oncolytic Virus Drug Treatment Product Offered
11.4.3 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Transgene SA Main Business Overview
11.4.5 Transgene SA Latest Developments
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Information
11.5.2 Oncolys BioPharma Oncolytic Virus Drug Treatment Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Oncolys BioPharma Main Business Overview
11.5.5 Oncolys BioPharma Latest Developments
11.6 Targovax
11.6.1 Targovax Company Information
11.6.2 Targovax Oncolytic Virus Drug Treatment Product Offered
11.6.3 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Targovax Main Business Overview
11.6.5 Targovax Latest Developments
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Information
11.7.2 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PsiOxus Therapeutics Main Business Overview
11.7.5 PsiOxus Therapeutics Latest Developments
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Information
11.8.2 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 SillaJen Biotherapeutics Main Business Overview
11.8.5 SillaJen Biotherapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Information
11.10.2 Lokon Pharma Oncolytic Virus Drug Treatment Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lokon Pharma Main Business Overview
11.10.5 Lokon Pharma Latest Developments
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Information
11.11.2 Genelux Corporation Oncolytic Virus Drug Treatment Product Offered
11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genelux Corporation Main Business Overview
11.11.5 Genelux Corporation Latest Developments
11.12 Vyriad
11.12.1 Vyriad Company Information
11.12.2 Vyriad Oncolytic Virus Drug Treatment Product Offered
11.12.3 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Vyriad Main Business Overview
11.12.5 Vyriad Latest Developments
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Information
11.13.2 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 TILT Biotherapeutics Main Business Overview
11.13.5 TILT Biotherapeutics Latest Developments
11.14 Cold Genesys
11.14.1 Cold Genesys Company Information
11.14.2 Cold Genesys Oncolytic Virus Drug Treatment Product Offered
11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Cold Genesys Main Business Overview
11.14.5 Cold Genesys Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Virus Drug Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Phase 1
Table 3. Major Players of Phase 2
Table 4. Major Players of Others
Table 5. Oncolytic Virus Drug Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 8. Oncolytic Virus Drug Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Oncolytic Virus Drug Treatment Revenue Market Share by Player (2018-2023)
Table 13. Oncolytic Virus Drug Treatment Key Players Head office and Products Offered
Table 14. Oncolytic Virus Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oncolytic Virus Drug Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Oncolytic Virus Drug Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Oncolytic Virus Drug Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Oncolytic Virus Drug Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Oncolytic Virus Drug Treatment
Table 46. Key Market Challenges & Risks of Oncolytic Virus Drug Treatment
Table 47. Key Industry Trends of Oncolytic Virus Drug Treatment
Table 48. Global Oncolytic Virus Drug Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Oncolytic Virus Drug Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Oncolytic Virus Drug Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Amgen Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 53. Amgen Oncolytic Virus Drug Treatment Product Offered
Table 54. Amgen Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Amgen Main Business
Table 56. Amgen Latest Developments
Table 57. Oncolytics Biotech Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 58. Oncolytics Biotech Oncolytic Virus Drug Treatment Product Offered
Table 59. Oncolytics Biotech Main Business
Table 60. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Oncolytics Biotech Latest Developments
Table 62. Viralytics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 63. Viralytics Oncolytic Virus Drug Treatment Product Offered
Table 64. Viralytics Main Business
Table 65. Viralytics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Viralytics Latest Developments
Table 67. Transgene SA Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 68. Transgene SA Oncolytic Virus Drug Treatment Product Offered
Table 69. Transgene SA Main Business
Table 70. Transgene SA Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Transgene SA Latest Developments
Table 72. Oncolys BioPharma Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 73. Oncolys BioPharma Oncolytic Virus Drug Treatment Product Offered
Table 74. Oncolys BioPharma Main Business
Table 75. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Oncolys BioPharma Latest Developments
Table 77. Targovax Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 78. Targovax Oncolytic Virus Drug Treatment Product Offered
Table 79. Targovax Main Business
Table 80. Targovax Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Targovax Latest Developments
Table 82. PsiOxus Therapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 83. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product Offered
Table 84. PsiOxus Therapeutics Main Business
Table 85. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. PsiOxus Therapeutics Latest Developments
Table 87. SillaJen Biotherapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 88. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
Table 89. SillaJen Biotherapeutics Main Business
Table 90. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. SillaJen Biotherapeutics Latest Developments
Table 92. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 93. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product Offered
Table 94. Sorrento Therapeutics Main Business
Table 95. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Sorrento Therapeutics Latest Developments
Table 97. Lokon Pharma Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 98. Lokon Pharma Oncolytic Virus Drug Treatment Product Offered
Table 99. Lokon Pharma Main Business
Table 100. Lokon Pharma Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lokon Pharma Latest Developments
Table 102. Genelux Corporation Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 103. Genelux Corporation Oncolytic Virus Drug Treatment Product Offered
Table 104. Genelux Corporation Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Genelux Corporation Main Business
Table 106. Genelux Corporation Latest Developments
Table 107. Vyriad Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 108. Vyriad Oncolytic Virus Drug Treatment Product Offered
Table 109. Vyriad Main Business
Table 110. Vyriad Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Vyriad Latest Developments
Table 112. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 113. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
Table 114. TILT Biotherapeutics Main Business
Table 115. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. TILT Biotherapeutics Latest Developments
Table 117. Cold Genesys Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 118. Cold Genesys Oncolytic Virus Drug Treatment Product Offered
Table 119. Cold Genesys Main Business
Table 120. Cold Genesys Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Cold Genesys Latest Developments
Table 1. Oncolytic Virus Drug Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Phase 1
Table 3. Major Players of Phase 2
Table 4. Major Players of Others
Table 5. Oncolytic Virus Drug Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 8. Oncolytic Virus Drug Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Oncolytic Virus Drug Treatment Revenue Market Share by Player (2018-2023)
Table 13. Oncolytic Virus Drug Treatment Key Players Head office and Products Offered
Table 14. Oncolytic Virus Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oncolytic Virus Drug Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Oncolytic Virus Drug Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Oncolytic Virus Drug Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Oncolytic Virus Drug Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Oncolytic Virus Drug Treatment
Table 46. Key Market Challenges & Risks of Oncolytic Virus Drug Treatment
Table 47. Key Industry Trends of Oncolytic Virus Drug Treatment
Table 48. Global Oncolytic Virus Drug Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Oncolytic Virus Drug Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Oncolytic Virus Drug Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Amgen Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 53. Amgen Oncolytic Virus Drug Treatment Product Offered
Table 54. Amgen Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Amgen Main Business
Table 56. Amgen Latest Developments
Table 57. Oncolytics Biotech Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 58. Oncolytics Biotech Oncolytic Virus Drug Treatment Product Offered
Table 59. Oncolytics Biotech Main Business
Table 60. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Oncolytics Biotech Latest Developments
Table 62. Viralytics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 63. Viralytics Oncolytic Virus Drug Treatment Product Offered
Table 64. Viralytics Main Business
Table 65. Viralytics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Viralytics Latest Developments
Table 67. Transgene SA Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 68. Transgene SA Oncolytic Virus Drug Treatment Product Offered
Table 69. Transgene SA Main Business
Table 70. Transgene SA Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Transgene SA Latest Developments
Table 72. Oncolys BioPharma Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 73. Oncolys BioPharma Oncolytic Virus Drug Treatment Product Offered
Table 74. Oncolys BioPharma Main Business
Table 75. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Oncolys BioPharma Latest Developments
Table 77. Targovax Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 78. Targovax Oncolytic Virus Drug Treatment Product Offered
Table 79. Targovax Main Business
Table 80. Targovax Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Targovax Latest Developments
Table 82. PsiOxus Therapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 83. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product Offered
Table 84. PsiOxus Therapeutics Main Business
Table 85. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. PsiOxus Therapeutics Latest Developments
Table 87. SillaJen Biotherapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 88. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
Table 89. SillaJen Biotherapeutics Main Business
Table 90. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. SillaJen Biotherapeutics Latest Developments
Table 92. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 93. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product Offered
Table 94. Sorrento Therapeutics Main Business
Table 95. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Sorrento Therapeutics Latest Developments
Table 97. Lokon Pharma Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 98. Lokon Pharma Oncolytic Virus Drug Treatment Product Offered
Table 99. Lokon Pharma Main Business
Table 100. Lokon Pharma Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Lokon Pharma Latest Developments
Table 102. Genelux Corporation Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 103. Genelux Corporation Oncolytic Virus Drug Treatment Product Offered
Table 104. Genelux Corporation Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Genelux Corporation Main Business
Table 106. Genelux Corporation Latest Developments
Table 107. Vyriad Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 108. Vyriad Oncolytic Virus Drug Treatment Product Offered
Table 109. Vyriad Main Business
Table 110. Vyriad Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Vyriad Latest Developments
Table 112. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 113. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product Offered
Table 114. TILT Biotherapeutics Main Business
Table 115. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. TILT Biotherapeutics Latest Developments
Table 117. Cold Genesys Details, Company Type, Oncolytic Virus Drug Treatment Area Served and Its Competitors
Table 118. Cold Genesys Oncolytic Virus Drug Treatment Product Offered
Table 119. Cold Genesys Main Business
Table 120. Cold Genesys Oncolytic Virus Drug Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Cold Genesys Latest Developments
LIST OF FIGURES
Figure 1. Oncolytic Virus Drug Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Drug Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncolytic Virus Drug Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncolytic Virus Drug Treatment Sales Market Share by Country/Region (2022)
Figure 8. Oncolytic Virus Drug Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2022
Figure 10. Oncolytic Virus Drug Treatment in Melanoma
Figure 11. Global Oncolytic Virus Drug Treatment Market: Melanoma (2018-2023) & ($ Millions)
Figure 12. Oncolytic Virus Drug Treatment in Prostate Cancer
Figure 13. Global Oncolytic Virus Drug Treatment Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Oncolytic Virus Drug Treatment in Breast Cancer
Figure 15. Global Oncolytic Virus Drug Treatment Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 16. Oncolytic Virus Drug Treatment in Ovarian Cancer
Figure 17. Global Oncolytic Virus Drug Treatment Market: Ovarian Cancer (2018-2023) & ($ Millions)
Figure 18. Oncolytic Virus Drug Treatment in Others
Figure 19. Global Oncolytic Virus Drug Treatment Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2022
Figure 21. Global Oncolytic Virus Drug Treatment Revenue Market Share by Player in 2022
Figure 22. Global Oncolytic Virus Drug Treatment Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 24. APAC Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 25. Europe Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 27. Americas Oncolytic Virus Drug Treatment Value Market Share by Country in 2022
Figure 28. United States Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Region in 2022
Figure 33. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2022
Figure 34. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2022
Figure 35. China Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Country in 2022
Figure 42. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Figure 43. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Figure 44. Germany Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 58. APAC Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Europe Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 61. United States Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Canada Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 65. China Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Japan Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Korea Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 69. India Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Australia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Germany Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 72. France Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 73. UK Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Italy Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Russia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Spain Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 79. Israel Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 82. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Oncolytic Virus Drug Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Drug Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncolytic Virus Drug Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncolytic Virus Drug Treatment Sales Market Share by Country/Region (2022)
Figure 8. Oncolytic Virus Drug Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2022
Figure 10. Oncolytic Virus Drug Treatment in Melanoma
Figure 11. Global Oncolytic Virus Drug Treatment Market: Melanoma (2018-2023) & ($ Millions)
Figure 12. Oncolytic Virus Drug Treatment in Prostate Cancer
Figure 13. Global Oncolytic Virus Drug Treatment Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Oncolytic Virus Drug Treatment in Breast Cancer
Figure 15. Global Oncolytic Virus Drug Treatment Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 16. Oncolytic Virus Drug Treatment in Ovarian Cancer
Figure 17. Global Oncolytic Virus Drug Treatment Market: Ovarian Cancer (2018-2023) & ($ Millions)
Figure 18. Oncolytic Virus Drug Treatment in Others
Figure 19. Global Oncolytic Virus Drug Treatment Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2022
Figure 21. Global Oncolytic Virus Drug Treatment Revenue Market Share by Player in 2022
Figure 22. Global Oncolytic Virus Drug Treatment Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 24. APAC Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 25. Europe Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Oncolytic Virus Drug Treatment Market Size 2018-2023 ($ Millions)
Figure 27. Americas Oncolytic Virus Drug Treatment Value Market Share by Country in 2022
Figure 28. United States Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Region in 2022
Figure 33. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2022
Figure 34. APAC Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2022
Figure 35. China Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Country in 2022
Figure 42. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Figure 43. Europe Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Figure 44. Germany Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Oncolytic Virus Drug Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 58. APAC Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Europe Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 61. United States Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Canada Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 65. China Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Japan Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Korea Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 69. India Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Australia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Germany Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 72. France Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 73. UK Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Italy Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Russia Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Spain Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 79. Israel Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Oncolytic Virus Drug Treatment Market Size 2024-2029 ($ Millions)
Figure 82. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Oncolytic Virus Drug Treatment Market Size Market Share Forecast by Application (2024-2029)
